28 November

08:30 – Registration & Welcome

09:00 – Keynote lecture : Carl H. June (Perelman School of Medicine, University of Pennsylvania)

T Cell therapy for Cancers

Chairmen : Eric Tartour (HEGP, Paris) and Jean-Christophe Bories (Hôpital Saint Louis, Paris)

09:45 – Session 4 : New cancer imaging tools

Chairwoman/man : Fathia Mami Chouaib (Gustave Roussy, Villejuif) and Jean-Jacques Fournié (Inserm, Toulouse)

Deciphering immune regulation within tumors
Sergio Quezada (UCL Cancer Institute, London)

Harnessing mutations for personalized cancer vaccine
Lelia Delamarre (GRME-South San Francisco)

10:45 – Coffee Break

11:15 – Session 5 : Cancer vaccines/Adoptive T cell immunotherapy/ Oncolytic viruses

Chairwoman/man : Claude Leclerc (Institut Pasteur, Paris) and Aurélien Marabelle (Gustave Roussy, Villejuif)

Chemotherapy to improve the therapeutic efficacy of cancer vaccines
Sjoerd van der Burg (Leiden University Medical Center, Leiden)

Precision T cell engineering to advance CAR therapy
Justin Eyquem (Memorial Sloan Kettering Cancer Center, New-York)

Translational development of the next generation of poxvirus-based immunotherapeutics
Eric Quemeneur (Transgène, Strasbourg)

12:45 – Lunch

14:00 – Session 6 : Targeting the tumor microenvironment for cancer immunotherapy

Chairwoman/man : Christophe Caux (CRCL, Lyon) and Lucie Peduto (Institut Pasteur, Paris)

Alteration of monocyte survival and immune dysfunctions in cancer
Vincenzo Bronté (VIMM, Padova)

Reprogramming the immunosuppressive tumor microenvironment
Michele De Palma (EPFL, Lausanne)

15:00 – Coffee Break

15:30 – Session 7 : Microbiota / Metabolism

Chairmen : François Valette (CRCNA, Nantes) and Marc Bonneville (Institut Mérieux, Lyon)

Tumor and host factors regulating anti-tumor immunity and immunotherapy efficacy
Thomas Gajewski (University of Chicago, Chicago)

The gut microbiome in cancer therapy
Laurence Zitvogel (Gustave Roussy, Villejuif)

Metabolic reprogramming enabling rapid CD8 T cell recall responses
Christoph Hess (University of Basel, Switzerland)

17:00 – Round table on latest discovery and development strategies in cancer immunotherapy

Chairwoman/men : Marc Bonneville, Lelia Delamarre and Eric Quemeneur

18:00 – Concluding remarks

Christine Chomienne, Claude Leclerc and Salem Chouaib